Neuro

Route 92 Medical Announces Publication of a Retrospective Study in the Interventional Neuroradiology Journal

SAN MATEO, Calif., July 31, 2023 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the publication of a first-in-human study featuring the FreeClimb® 70 reperfusion system in the Interventional Neuroradiology Journal. The study, conducted across five U.S. centers and one international […]

Aidoc Introduces the First and Only AI-Powered Solution to Identify Suspected Posterior and Anterior Large and Medium Vessel Occlusions

NEW YORK, July 31, 2023 /PRNewswire/ — Aidoc, a pioneering force in clinical AI, announced today the launch of its revolutionary Full Brain Solution. This new solution will significantly expand the anatomy analyzed by AI to identify suspected strokes, allowing for identification and care coordination of patients with medium vessel occlusions […]

Imperative Care Announces Multiple Poster Presentations on the Zoom Stroke Solution at the Society of NeuroInterventional Surgery 20th Annual Meeting

CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced that new data from studies evaluating the Zoom Stroke Solution for the treatment of ischemic stroke will be presented at the Society of NeuroInterventional Surgery […]

Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care

GUILFORD, Conn.–(BUSINESS WIRE)– Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, has announced the commencement of an international, multi-site observational study, ACTION PMR (ACuTe Ischemic strOke detectioN with Portable MR). To support its acute stroke care initiatives, […]

MedRhythms Announces FDA Listing of InTandem™ (MR-001) to Improve Walking and Ambulation in Adults with Chronic Stroke

Stroke is a leading cause of long-term disability, and over half of people aged 65 or older who have had a stroke experience reduced mobility and gait deficits PORTLAND, Maine, July 6, 2023 /PRNewswire/ — MedRhythms today announced that MR-001, the company’s evidence-based neurorehabilitation system to improve walking and ambulation in adults with chronic […]

MicroVention Reshapes Stroke Therapy with the Introduction of the ERIC™ Retrieval Device; ERIC Delivers Thrombus Control, Procedure Efficiency and Versatility When Every Second Counts

MicroVention Now Offers a Fully Integrated, Comprehensive Stroke Portfolio, Delivering Breakthrough Innovation from Access to Revascularization ALISO VIEJO, Calif.–(BUSINESS WIRE)–MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the ERIC Retrieval Device is now commercially available in the United States for ischemic stroke treatment. ERIC received […]

Sensome and Asahi Intecc Forge Partnership to Develop Next-Generation Smart Guidewire and Transform Stroke Treatment

PARIS–(BUSINESS WIRE)–Pioneering smart medical device company, Sensome, and world-leading Japanese guidewire company, Asahi Intecc, are announcing today a collaboration to develop the next generation Clotild® Smart Guidewire, with Asahi Intecc taking on the manufacturing role for this groundbreaking device destined for the treatment of acute ischemic stroke. Acute ischemic stroke is […]

DiaMedica Therapeutics Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke

MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today that the U.S. Food and Drug Administration (FDA) has removed the clinical hold placed on the investigational new drug application for its ReMEDy2 phase 2/3 clinical trial […]

Philips’ direct-to-angio stroke pathway: new analysis demonstrates substantial cost savings in addition to improved patient outcomes

Economic analysis of cost of Vall d’Hebron University Hospital Stroke Unit shows direct-to-angio stroke pathway can save more than USD 3,000 per patient Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of a health economic analysis published in the Journal of NeuroInterventional […]

Imperative Care Announces Positive New Data Demonstrating Benefits of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy

Early Data Published in JNIS Showcases Safety and Technical Feasibility of Zoom RDL Across a Range of Neurointerventional Procedures CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced the publication of early clinical data […]